- Home
- IKT vs PHX Comparison
IKT vs PHX Comparison
Compare IKT & PHX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IKT
- PHX
- Stock Information
- Founded
- IKT 2008
- PHX 1926
- Country
- IKT United States
- PHX United States
- Employees
- IKT N/A
- PHX N/A
- Industry
- IKT Biotechnology: Pharmaceutical Preparations
- PHX Oil & Gas Production
- Sector
- IKT Health Care
- PHX Energy
- Exchange
- IKT Nasdaq
- PHX Nasdaq
- Market Cap
- IKT 159.2M
- PHX 137.2M
- IPO Year
- IKT 2020
- PHX N/A
- Fundamental
- Price
- IKT $2.96
- PHX $3.42
- Analyst Decision
- IKT Strong Buy
- PHX Strong Buy
- Analyst Count
- IKT 1
- PHX 2
- Target Price
- IKT $5.00
- PHX $4.90
- AVG Volume (30 Days)
- IKT 318.4K
- PHX 53.2K
- Earning Date
- IKT 11-12-2024
- PHX 11-06-2024
- Dividend Yield
- IKT N/A
- PHX 4.54%
- EPS Growth
- IKT N/A
- PHX N/A
- EPS
- IKT N/A
- PHX 0.13
- Revenue
- IKT $79,570.00
- PHX $34,611,970.00
- Revenue This Year
- IKT N/A
- PHX $5.46
- Revenue Next Year
- IKT N/A
- PHX $23.19
- P/E Ratio
- IKT N/A
- PHX $26.84
- Revenue Growth
- IKT N/A
- PHX N/A
- 52 Week Low
- IKT $0.80
- PHX $2.95
- 52 Week High
- IKT $3.82
- PHX $3.74
- Technical
- Relative Strength Index (RSI)
- IKT 76.96
- PHX 47.73
- Support Level
- IKT $2.56
- PHX $3.36
- Resistance Level
- IKT $2.75
- PHX $3.70
- Average True Range (ATR)
- IKT 0.27
- PHX 0.12
- MACD
- IKT 0.03
- PHX -0.03
- Stochastic Oscillator
- IKT 96.43
- PHX 41.84
About IKT Inhibikase Therapeutics Inc.
Inhibikase Therapeutics Inc is a a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of Parkinson's disease ("PD"), Parkinson's-related disorders and other diseases of the Abelson Tyrosine Kinases. Its multi-therapeutic pipeline has a primary focus on neurodegeneration and its program utilizing Risvodetinib (also known as IkT-148009), a selective inhibitor of the non-receptor Abelson Tyrosine Kinases, targets the treatment of Parkinson's disease inside and outside the brain as well as other diseases that arise from Abelson Tyrosine Kinases.
About PHX PHX Minerals Inc.
PHX Minerals Inc is an oil and natural gas mineral company that has employed a plan to shift the core of its business away from drilling and toward perpetual mineral and natural gas ownership. The company owns substantial mineral acreage, principally in Oklahoma, North Dakota, Texas, New Mexico, and Arkansas, but still maintains legacy interests in natural gas and oil properties that have retired operations. The revenues is derived from royalties granted from the production and sale of natural gas, oil and NGL, and the remaining portion of its revenues is derived from the production and sale of natural gas, oil and NGL on its working interests.